TickerFactsScreenerDevelopers

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$881.7K2011: -$1.87M2012: -$2.11M2013: -$1.37M2014: -$2.40M2015: -$2.65M2016: -$2.13M2017: -$1.81M2018: -$2.14M2019: -$2.49M2020: -$3.27M2021: -$6.72M2022: -$6.31M2023: -$5.09M2024: -$3.57M2025: -$5.11M-$5.11M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$5.11M-43.0%
2024-$3.57M+29.8%
2023-$5.09M+19.3%
2022-$6.31M+6.1%
2021-$6.72M-105.7%
2020-$3.27M-31.2%
2019-$2.49M-16.5%
2018-$2.14M-18.1%
2017-$1.81M+15.2%
2016-$2.13M+19.3%
2015-$2.65M-10.1%
2014-$2.40M-74.8%
2013-$1.37M+34.7%
2012-$2.11M-12.7%
2011-$1.87M-111.9%
2010-$881.7K—